How He Maintained A Staggering 97% Trading Win Rate Over 6+ Years

Economic Downturns, Pandemics, Wars—Nothing Shakes His Portfolio. He's Had Unearthly Wins In Both Bull And Bear Markets.

For Close To A Decade, He’s Maintained A Staggering 97% Trading Win Rate. He Didn't Follow The Wall Street Playbook, And Still Became A Millionaire Trader By The Age Of 37!

Watch His Exclusive Tell-All Interview Here Now

AKRO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.69%

Insider Buying (Last 12 Months): $8,453,700.00

Insider Selling (Last 12 Months): $100,425,473.80

Akero Therapeutics Insider Trading History Chart

Akero Therapeutics Share Price & Price History

^$48.20

▲ +1.34 (2.86%)

As of 09/28/2023 01:00 AM ET

Days: 30 | 90 | 365

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

Akero Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/21/2023	Catriona Yale	Insider	Sell	5,000	$48.07	$240,350.00	46,010
9/13/2023	Andrew Cheng	CEO	Sell	1,682	$50.34	$84,671.88	460,998
9/13/2023	Catriona Yale	Insider	Sell	617	$50.34	$31,059.78	46,010
9/13/2023	Jonathan Young	COO	Sell	562	$50.34	$28,291.08	183,177
9/13/2023	William Richard White	CFO	Sell	632	$50.34	$31,814.88	18,468
9/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.77	$1,244,250.00	462,680
8/28/2023	Catriona Yale	Insider	Sell	5,745	$49.99	$287,192.55	46,627
8/8/2023	G. Walmsley Graham	Director	Buy	25,000	$42.06	$1,051,500.00	600,000
8/1/2023	G. Walmsley Graham	Director	Buy	25,000	$43.26	$1,081,500.00	575,000
7/28/2023	G. Walmsley Graham	Director	Buy	30,000	$42.69	$1,280,700.00	550,000
7/3/2023	Andrew Cheng	CEO	Sell	25,000	$44.88	$1,122,000.00	447,680
6/23/2023	Catriona Yale	Insider	Sell	11,000	$50.76	$558,360.00	46,627
6/21/2023	Catriona Yale	Insider	Sell	11,349	$52.26	$593,098.74	68,627
6/20/2023	William Richard White	CFO	Sell	20,777	$55.00	$1,142,735.00	19,100
6/16/2023	Timothy Rolph	Insider	Sell	78,200	$54.78	$4,283,796.00	151,220
6/16/2023	Tomas J. Heyman	Director	Sell	26,000	$54.67	$1,421,420.00
6/13/2023	Andrew Cheng	CEO	Sell	1,613	$55.16	$88,973.08	407,680
6/13/2023	Jonathan Young	COO	Sell	538	$55.16	$29,676.08	183,739
6/13/2023	Timothy Rolph	Insider	Sell	509	$55.16	$28,076.44	189,420
6/13/2023	William Richard White	CFO	Sell	606	$55.16	$33,426.96	22,377
6/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.10	$1,127,500.00	409,293
5/19/2023	G. Walmsley Graham	Director	Buy	120,000	$42.00	$5,040,000.00	520,000
5/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.07	$1,126,750.00	409,293
4/3/2023	Andrew Cheng	CEO	Sell	25,000	$37.94	$948,500.00	369,293
3/1/2023	Andrew Cheng	CEO	Sell	25,000	$46.65	$1,166,250.00	370,999
2/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.06	$1,226,500.00	370,999
1/13/2023	Catriona Yale	Insider	Sell	5,000	$50.53	$252,650.00	81,268
1/3/2023	Andrew Cheng	CEO	Sell	25,000	$51.27	$1,281,750.00	370,999
1/3/2023	Jonathan Young	COO	Sell	8,777	$54.64	$479,575.28	184,911
12/28/2022	Timothy Rolph	Insider	Sell	1,700	$50.00	$85,000.00	203,032
12/28/2022	William Richard White	CFO	Sell	999	$49.76	$49,710.24	23,624
12/27/2022	Jonathan Young	COO	Sell	12,500	$49.57	$619,625.00	182,449
12/12/2022	Catriona Yale	Insider	Sell	5,000	$43.23	$216,150.00	86,268
12/1/2022	Andrew Cheng	CEO	Sell	10,000	$46.07	$460,700.00	310,148
12/1/2022	Skorpios Trust	Major Shareholder	Sell	1,636,000	$43.50	$71,166,000.00	3,271,829
11/30/2022	Seth Loring Harrison	Director	Sell	11,101	$46.94	$521,080.94	136,301
11/15/2022	Timothy Rolph	Insider	Sell	3,138	$45.04	$141,335.52	187,784
11/10/2022	Catriona Yale	Insider	Sell	5,000	$39.42	$197,100.00	72,073
11/1/2022	Andrew Cheng	CEO	Sell	10,000	$43.42	$434,200.00	310,148
10/27/2022	Seth Loring Harrison	Director	Sell	66,426	$41.53	$2,758,671.78	168,540
10/25/2022	Jonathan Young	COO	Sell	12,500	$44.72	$559,000.00	163,254
10/25/2022	Seth Loring Harrison	Director	Sell	4,515	$44.92	$202,813.80	300,851
10/25/2022	Timothy Rolph	Insider	Sell	10,653	$45.09	$480,343.77	195,684
10/13/2022	William Richard White	CFO	Sell	20,000	$39.82	$796,400.00	4,429
10/10/2022	Catriona Yale	Insider	Sell	5,000	$37.99	$189,950.00	77,073
10/6/2022	Timothy Rolph	Insider	Sell	22,500	$39.29	$884,025.00	186,337
10/3/2022	Andrew Cheng	CEO	Sell	10,000	$33.23	$332,300.00	310,148
9/30/2022	Timothy Rolph	Insider	Sell	45,000	$32.72	$1,472,400.00	198,837
9/13/2022	Andrew Cheng	CEO	Sell	60,000	$27.42	$1,645,200.00	310,148
9/13/2022	Catriona Yale	Insider	Sell	40,000	$27.48	$1,099,200.00	82,073
9/13/2022	William Richard White	CFO	Sell	32,500	$27.03	$878,475.00	4,429
3/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.59	$175,900.00
2/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.56	$175,600.00
1/14/2022	William Richard White	CFO	Sell	9,700	$22.03	$213,691.00
1/10/2022	Andrew Cheng	CEO	Sell	10,000	$19.55	$195,500.00
12/21/2021	William Richard White	CFO	Sell	100	$22.00	$2,200.00
12/17/2021	William Richard White	CFO	Sell	3,200	$22.04	$70,528.00
11/3/2021	Jonathan Young	COO	Sell	18,780	$24.27	$455,790.60
10/15/2021	Catriona Yale	Insider	Sell	12,500	$21.59	$269,875.00
8/16/2021	Catriona Yale	Insider	Sell	10,000	$18.79	$187,900.00	145,921
8/3/2021	Andrew Cheng	CEO	Sell	17,500	$20.83	$364,525.00
8/2/2021	William Richard White	CFO	Sell	4,441	$22.03	$97,835.23	7,718
7/15/2021	Catriona Yale	Insider	Sell	10,000	$20.90	$209,000.00
7/6/2021	William Richard White	CFO	Sell	6,500	$24.52	$159,380.00	9,777
7/2/2021	Andrew Cheng	CEO	Sell	17,500	$24.78	$433,650.00
6/1/2021	Kevin Bitterman	Director	Sell	17,489	$26.28	$459,610.92
4/1/2021	Jonathan Young	COO	Sell	3,055	$28.75	$87,831.25	170,120
4/1/2021	William Richard White	CFO	Sell	50,000	$28.64	$1,432,000.00	52,270
3/1/2021	Jonathan Young	COO	Sell	3,055	$30.48	$93,116.40	173,375
2/1/2021	Jonathan Young	COO	Sell	3,055	$29.24	$89,328.20
1/8/2021	Jonathan Young	COO	Sell	10,000	$28.12	$281,200.00	189,285
1/4/2021	Jonathan Young	COO	Sell	3,060	$25.29	$77,387.40	181,885
10/9/2020	Kevin Bitterman	Director	Sell	13,000	$28.93	$376,090.00

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

SEC Filings (Institutional Ownership Changes) for Akero Therapeutics (NASDAQ:AKRO)

Institutional Buying and Selling by Quarter

Akero Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/24/2023	Perceptive Advisors LLC	1,940,675	$90.61M	2.6%	+270.7%	3.490%
8/21/2023	California State Teachers Retirement System	53,891	$2.52M	0.0%	+35.8%	0.097%
8/21/2023	Osaic Holdings Inc.	1,809	$84K	0.0%	+24.8%	0.003%
8/15/2023	Alliancebernstein L.P.	120,405	$5.62M	0.0%	+63.0%	0.240%
8/15/2023	Wells Fargo & Company MN	48,451	$2.26M	0.0%	+32.3%	0.097%
8/15/2023	Yiheng Capital Management L.P.	1,201,591	$56.10M	3.0%	-6.8%	2.398%
8/15/2023	Goldman Sachs Group Inc.	209,043	$9.76M	0.0%	-6.4%	0.417%
8/15/2023	Lazard Asset Management LLC	6,349	$0.30M	0.0%	N/A	0.013%
8/15/2023	Royal Bank of Canada	4,850	$0.23M	0.0%	+45.9%	0.010%
8/15/2023	Boxer Capital LLC	1,676,733	$78.29M	3.6%	+101.7%	3.347%
8/15/2023	Commodore Capital LP	1,675,000	$78.21M	8.8%	+112.0%	3.343%
8/14/2023	Cormorant Asset Management LP	115,000	$5.37M	0.3%	N/A	0.230%
8/14/2023	Tower Research Capital LLC TRC	1,998	$93K	0.0%	-49.2%	0.004%
8/14/2023	Schonfeld Strategic Advisors LLC	175,200	$8.18M	0.1%	+193.6%	0.350%
8/14/2023	Marshall Wace LLP	923,058	$43.10M	0.1%	-14.7%	1.842%
8/14/2023	State of Wisconsin Investment Board	41,286	$1.93M	0.0%	+37.1%	0.082%
8/14/2023	State Street Corp	2,240,231	$104.60M	0.0%	+0.4%	4.472%
8/14/2023	Bellevue Group AG	27,100	$1.27M	0.0%	+3.8%	0.054%
8/14/2023	UniSuper Management Pty Ltd	259,147	$12.10M	0.1%	N/A	0.517%
8/14/2023	Rock Springs Capital Management LP	1,550,754	$72.41M	1.7%	+6.6%	3.095%
8/14/2023	Nuveen Asset Management LLC	123,892	$5.79M	0.0%	+34.1%	0.223%
8/11/2023	Nan Fung Group Holdings Ltd	4,425	$0.21M	0.1%	N/A	0.009%
8/11/2023	Credit Suisse AG	50,619	$2.36M	0.0%	+80.3%	0.101%
8/11/2023	BlackRock Inc.	3,321,153	$155.07M	0.0%	+19.3%	6.629%
8/11/2023	Ameritas Investment Partners Inc.	3,710	$0.17M	0.0%	+33.0%	0.007%
8/11/2023	General Atlantic L.P.	1,785,714	$83.38M	1.3%	N/A	3.564%
8/11/2023	Campbell & CO Investment Adviser LLC	17,950	$0.84M	0.1%	N/A	0.036%
8/11/2023	State Board of Administration of Florida Retirement System	12,750	$0.60M	0.0%	+34.8%	0.025%
8/11/2023	The Manufacturers Life Insurance Company	64,430	$3.01M	0.0%	+11.7%	0.129%
8/11/2023	Franklin Resources Inc.	18,245	$0.85M	0.0%	N/A	0.036%
8/11/2023	Trexquant Investment LP	10,073	$0.47M	0.0%	N/A	0.020%
8/11/2023	Geode Capital Management LLC	824,707	$38.51M	0.0%	+23.8%	1.646%
8/11/2023	Sei Investments Co.	13,624	$0.64M	0.0%	+17.4%	0.027%
8/11/2023	E Fund Management Co. Ltd.	8,510	$0.40M	0.0%	-8.9%	0.017%
8/11/2023	Northern Trust Corp	460,429	$21.50M	0.0%	+28.7%	0.919%
8/10/2023	MetLife Investment Management LLC	23,684	$1.11M	0.0%	+29.6%	0.047%
8/10/2023	Osaic Holdings Inc.	1,809	$84K	0.0%	+24.8%	0.004%
8/10/2023	Metropolitan Life Insurance Co NY	2,454	$0.12M	0.0%	+23.9%	0.005%
8/10/2023	ProShare Advisors LLC	9,423	$0.44M	0.0%	+28.3%	0.019%
8/10/2023	Profund Advisors LLC	28,994	$1.35M	0.1%	-5.2%	0.058%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	26,819	$1.24M	0.0%	+19.3%	0.054%
8/10/2023	Artisan Partners Limited Partnership	237,584	$11.09M	0.0%	-0.1%	0.474%
8/10/2023	US Bancorp DE	3,661	$0.17M	0.0%	+13.5%	0.007%
8/10/2023	Charles Schwab Investment Management Inc.	294,662	$13.76M	0.0%	+23.6%	0.588%
8/10/2023	Tekla Capital Management LLC	61,497	$2.87M	0.1%	N/A	0.123%
8/9/2023	Dimensional Fund Advisors LP	268,917	$12.55M	0.0%	-5.1%	0.537%
8/9/2023	BNP Paribas Arbitrage SNC	35,474	$1.66M	0.0%	-45.0%	0.071%
8/9/2023	TD Asset Management Inc	62,746	$2.93M	0.0%	+8.1%	0.125%
8/9/2023	Swiss National Bank	96,300	$4.50M	0.0%	+46.8%	0.192%
8/8/2023	Rhumbline Advisers	61,174	$2.86M	0.0%	+11.5%	0.122%
8/8/2023	Candriam S.C.A.	115,000	$5.37M	0.0%	+9.5%	0.230%
8/8/2023	Chicago Partners Investment Group LLC	25,200	$1.13M	0.1%	-4.3%	0.050%
8/8/2023	International Biotechnology Trust PLC	78,489	$3.66M	1.1%	N/A	0.157%
8/7/2023	Principal Financial Group Inc.	11,386	$0.53M	0.0%	+6.8%	0.023%
8/4/2023	Parallel Advisors LLC	5,510	$0.26M	0.0%	-4.3%	0.011%
8/4/2023	American International Group Inc.	21,624	$1.01M	0.0%	+28.5%	0.043%
8/3/2023	Barclays PLC	143,078	$6.68M	0.0%	+85.3%	0.257%
8/3/2023	Skorpios Trust	1,621,829	$75.72M	32.9%	-50.4%	3.237%
8/3/2023	Bank of New York Mellon Corp	153,928	$7.19M	0.0%	+25.6%	0.307%
8/2/2023	State of New Jersey Common Pension Fund D	53,742	$2.51M	0.0%	N/A	0.107%
8/2/2023	Woodmont Investment Counsel LLC	6,620	$0.31M	0.0%	-7.0%	0.013%
8/2/2023	Handelsbanken Fonder AB	9,500	$0.44M	0.0%	+37.7%	0.019%
8/1/2023	Arizona State Retirement System	12,432	$0.58M	0.0%	+41.2%	0.025%
7/27/2023	Victory Capital Management Inc.	297,572	$13.89M	0.0%	+46.2%	0.594%
7/20/2023	Global Retirement Partners LLC	4,379	$0.20M	0.0%	N/A	0.009%
7/20/2023	Bailard Inc.	5,027	$0.24M	0.0%	-30.4%	0.010%
7/19/2023	Teacher Retirement System of Texas	12,007	$0.56M	0.0%	+28.2%	0.024%
7/10/2023	SG Americas Securities LLC	7,986	$0.37M	0.0%	+23.1%	0.016%
5/26/2023	ProShare Advisors LLC	7,345	$0.28M	0.0%	-12.1%	0.015%
5/22/2023	Ameriprise Financial Inc.	5,632	$0.22M	0.0%	-61.2%	0.011%
5/18/2023	New York State Common Retirement Fund	27,682	$1.06M	0.0%	-15.2%	0.055%
5/16/2023	Perceptive Advisors LLC	523,525	$20.03M	0.6%	+49.4%	1.081%
5/16/2023	State Street Corp	2,230,807	$85.35M	0.0%	-10.8%	4.607%
5/16/2023	Squarepoint Ops LLC	20,091	$0.77M	0.0%	-25.7%	0.041%
5/16/2023	Geode Capital Management LLC	665,927	$25.48M	0.0%	+5.1%	1.375%
5/16/2023	Hhlr Advisors LTD.	295,502	$11.31M	0.2%	-6.3%	0.610%
5/16/2023	AQR Capital Management LLC	29,996	$1.15M	0.0%	+119.2%	0.062%
5/15/2023	Schonfeld Strategic Advisors LLC	59,678	$2.28M	0.0%	-39.2%	0.123%
5/15/2023	Cubist Systematic Strategies LLC	19,778	$0.76M	0.0%	-82.9%	0.041%
5/15/2023	Commodore Capital LP	790,000	$30.23M	4.6%	+47.1%	1.631%
5/15/2023	Two Sigma Advisers LP	18,200	$0.70M	0.0%	-13.7%	0.038%
5/15/2023	Two Sigma Investments LP	34,000	$1.30M	0.0%	-19.7%	0.070%
5/15/2023	Deutsche Bank AG	519,575	$19.88M	0.0%	+21.5%	1.073%
5/15/2023	Ensign Peak Advisors Inc	175,564	$6.72M	0.0%	+7.5%	0.363%
5/15/2023	Price T Rowe Associates Inc. MD	2,623,680	$100.38M	0.0%	+9.3%	5.418%
5/15/2023	Boothbay Fund Management LLC	10,035	$0.38M	0.0%	N/A	0.021%
5/15/2023	Ghost Tree Capital LLC	275,000	$10.52M	3.1%	+223.5%	0.568%
5/15/2023	XTX Topco Ltd	7,470	$0.29M	0.1%	N/A	0.015%
5/12/2023	Renaissance Technologies LLC	168,900	$6.46M	0.0%	+149.9%	0.349%
5/12/2023	Candriam S.C.A.	105,000	$3.70M	0.0%	-50.0%	0.217%
5/12/2023	BlackRock Inc.	2,783,377	$106.49M	0.0%	+0.9%	5.748%
5/12/2023	Long Focus Capital Management LLC	62,904	$2.41M	0.3%	-61.6%	0.130%
5/12/2023	BNP Paribas Arbitrage SNC	64,517	$2.47M	0.0%	+70.9%	0.133%
5/12/2023	Bank of America Corp DE	231,421	$8.85M	0.0%	+14.3%	0.478%
5/12/2023	Boulder Hill Capital Management LP	5,900	$0.23M	0.2%	N/A	0.012%
5/12/2023	HRT Financial LP	16,489	$0.63M	0.0%	N/A	0.034%
5/12/2023	Sei Investments Co.	11,600	$0.44M	0.0%	-24.1%	0.024%
5/12/2023	Dimensional Fund Advisors LP	283,516	$10.85M	0.0%	-2.4%	0.585%
5/12/2023	Wellington Management Group LLP	1,160,542	$44.40M	0.0%	+32.5%	2.397%
5/12/2023	ProShare Advisors LLC	7,345	$0.28M	0.0%	-12.1%	0.015%

Data available starting January 2016

Akero Therapeutics, Inc., a clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company is also conducting a Phase 2b clinical trial to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Today's Range

Now: $48.20

$46.15

$48.26

50 Day Range

MA: $46.92

$41.19

$52.25

52 Week Range

Now: $48.20

$27.80

$58.38

Volume

801,149 shs

Average Volume

681,089 shs

Market Capitalization

$2.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Akero Therapeutics?: Akero Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Seth Loring Harrison (Director)
Timothy Rolph (Insider)
Jonathan Young (COO)
Catriona Yale (Insider)
William Richard White (CFO)
Tomas J Heyman (Director)
Learn More about top insider investors at Akero Therapeutics.
Who are the major institutional investors of Akero Therapeutics?: Akero Therapeutics' top institutional investors include:
BlackRock Inc. — 6.63%
State Street Corp — 4.47%
Perceptive Advisors LLC — 3.49%
General Atlantic L.P. — 3.56%
Boxer Capital LLC — 3.35%
Commodore Capital LP — 3.34%
Learn More about top institutional investors of Akero Therapeutics stock.
Which institutional investors are selling Akero Therapeutics stock?: In the last quarter, AKRO stock was sold by these institutional investors:
Skorpios Trust
Marshall Wace LLP
Yiheng Capital Management L.P.
Caption Management LLC
Jefferies Financial Group Inc.
BNP Paribas Arbitrage SNC
Dimensional Fund Advisors LP
Goldman Sachs Group Inc.
In the previous year, company insiders that have sold Akero Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Seth Loring Harrison (Director)
Timothy Rolph (Insider)
Jonathan Young (COO)
Catriona Yale (Insider)
William Richard White (CFO)
Learn More investors selling Akero Therapeutics stock.
Which institutional investors are buying Akero Therapeutics stock?: During the last quarter, AKRO stock was purchased by institutional investors including:
General Atlantic L.P.
Perceptive Advisors LLC
Commodore Capital LP
Boxer Capital LLC
BlackRock Inc.
UniSuper Management Pty Ltd
Geode Capital Management LLC
Schonfeld Strategic Advisors LLC